Health
Internal AstraZeneca safety report sheds light on neurological condition suffered by vaccine trial participant – CTV News
An internal safety report by pharmaceutical giant AstraZeneca describes how a participant in its vaccine trial developed trouble walking, weakness and pain in her arms, and other symptoms.
CNN has obtained an internal safety report by pharmaceutical giant AstraZeneca that sheds light on the neurological condition suffered by one of the participants in its coronavirus vaccine clinical trial.
The report details how the study volunteer, a previously healthy 37-year-old woman, “experienced confirmed transverse myelitis” after receiving her second dose of the vaccine, and was hospitalized on September 5.
Four days later, AstraZeneca dismissed media reports about the participant havin…
-
Noosa News20 hours agoChef Sophie Phipps prepares to open restaurant at 30-acre Alsahwa Estate
-
General12 hours ago‘Sovereign citizens’ sentenced to prison term in Western Australia for defiance of court order
-
Noosa News19 hours agoSpectacles of Wonder
-
Noosa News21 hours agoTeens help keep their Riverina family farm running